Demographic Differences Across ANA Groups

Dr. Vivian Kawai and Matthew Chung discuss their research on the clinical significance of high-titer antinuclear antibodies (ANA) using electronic medical record data and PheWAS analysis. They explore the study's design, key findings, clinical implications, and limitations, while also discussing how an undergraduate research experience evolved into a successful mentorship and publication.

Clinical Conditions Associated With a High Antinuclear Antibody Titer in Individuals Without Autoimmune Disease